GoodRx interim CEO Scott Wagner extends commitment; two board directors resign

GoodRx Holdings, Inc.

Scott Wagner's employment agreement revised to indefinite term, annual cash bonus target 100% of base salary.
Wagner granted $8M in equity ($4M options, $4M RSUs) vesting monthly over eight months starting May 8, 2024.
Stephen LeSieur resigns from board effective March 14, 2024; Adam Karol resigns effective March 22, 2024.
Both directors cited no disagreement; LeSieur departure follows repurchase of Spectrum shares from him.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Adam Karol

Director

GDRX · GoodRx Holdings, Inc.

Effective: 2024-03-22
Filed: March 14, 2024, 7:59 PM ET

On March 12, 2024, Adam Karol notified the Company of his decision to resign as a member of the Board, effective as of March 22, 2024, including from his service on the Board’s Compliance Committee and Nominating and Corporate Governance Committee.

Departed

Stephen LeSieur

Director

GDRX · GoodRx Holdings, Inc.

Effective: 2024-03-14
Filed: March 14, 2024, 7:59 PM ET

Also on March 12, 2024, Stephen LeSieur notified the Company of his decision to resign as a member of the Board, effective as of March 14, 2024, including from his service on the Board’s Compliance Committee.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Adam Karol resigned as Director at GoodRx Holdings, Inc..

Action: resigned
Role: Director

Exact text from the filing

On March 12, 2024, Adam Karol notified the Company of his decision to resign as a member of the Board, effective as of March 22, 2024, including from his service on the Board’s Compliance Committee and Nominating and Corporate Governance Committee.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Stephen LeSieur resigned as Director at GoodRx Holdings, Inc..

Action: resigned
Role: Director

Exact text from the filing

Also on March 12, 2024, Stephen LeSieur notified the Company of his decision to resign as a member of the Board, effective as of March 14, 2024, including from his service on the Board’s Compliance Committee.

View on SEC.gov

GoodRx Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001809519-24-000048

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.